Kodak divestiture of Sterling Winthrop
This article was originally published in The Tan Sheet
Executive Summary
Elf Sanofi is interested in acquiring Sterling's U.S. prescription drug business as well as the company's international OTC and prescription operations. In a story on the Sterling Winthrop divestiture (May 9, p. 1), "The Tan Sheet" incorrectly reported that Sanofi is only interested in acquiring Sterling's overseas businesses